
Viridian Therapeutics VRDN
€ 28.04
1.83%
Quartalsbericht 2025-Q3
hinzugefügt 05.11.2025
Viridian Therapeutics EV 2011-2025 | VRDN
EV Jährlich Viridian Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.11 B | 1.01 B | 822 M | 189 M | 35.4 M | -10.3 M | -17.8 M | -33.5 M | 1.24 M | -8.34 M | -3.02 M | 1.44 M | 24.2 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.11 B | -33.5 M | 240 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
457 M | $ 4.93 | 4.78 % | $ 818 M | ||
|
Aclaris Therapeutics
ACRS
|
192 M | $ 3.2 | -1.69 % | $ 247 M | ||
|
AlloVir
ALVR
|
-64.1 M | - | 4.14 % | $ 49.1 M | ||
|
Aptevo Therapeutics
APVO
|
3.01 M | $ 1.07 | -5.75 % | $ 295 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
726 M | $ 213.33 | -3.22 % | $ 5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.13 | -4.96 % | $ 7.53 B | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
BioVie
BIVI
|
-12.6 M | $ 1.42 | -1.85 % | $ 2.1 M | ||
|
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
2.15 B | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
-6.64 B | $ 93.93 | -0.93 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
725 M | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
2 B | $ 26.45 | 4.67 % | $ 1.28 B | ||
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | ||
|
Anika Therapeutics
ANIK
|
300 M | $ 9.6 | 0.37 % | $ 141 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 0.26 | -6.98 % | $ 566 M | ||
|
Catalyst Biosciences
CBIO
|
38.1 M | $ 12.98 | -7.91 % | $ 854 M | ||
|
Arena Pharmaceuticals
ARNA
|
5.65 B | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
-37.4 M | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | ||
|
Avenue Therapeutics
ATXI
|
-1.23 M | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | ||
|
Axon Enterprise
AXON
|
41.5 B | $ 548.58 | -2.78 % | $ 41.6 B | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-15.2 M | $ 2.37 | 2.83 % | $ 14.9 M | ||
|
AstraZeneca PLC
AZN
|
57.7 B | $ 91.59 | 1.95 % | $ 96.9 B | ||
|
Celldex Therapeutics
CLDX
|
18.3 M | $ 27.09 | -1.53 % | $ 1.74 M | ||
|
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
3.22 B | $ 8.97 | -0.44 % | $ 1.45 B | ||
|
BeiGene, Ltd.
BGNE
|
253 B | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
10.2 B | $ 11.33 | -1.78 % | $ 733 M | ||
|
Biogen
BIIB
|
28.3 B | $ 175.2 | 0.63 % | $ 25.5 B | ||
|
Abeona Therapeutics
ABEO
|
184 M | $ 5.07 | -5.5 % | $ 108 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
6.58 B | $ 87.67 | -0.36 % | $ 9.05 B | ||
|
ADiTx Therapeutics
ADTX
|
23.1 M | $ 1.43 | -36.18 % | $ 18.8 K | ||
|
Cellectar Biosciences
CLRB
|
60.8 M | $ 3.28 | -9.39 % | $ 40.1 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
-9.74 M | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | ||
|
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
2.05 B | $ 24.29 | 2.84 % | $ 2.88 B |